Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
Order of Malta’s Grand Master praises UNESCO’s commitment to progress and respect of human dignity
11/13/2019. In an epoch marked by serious conflicts and crisis situations that seem insuperable: “UNESCO’s action is even more deserving of our gratitude,” said the Grand Master
Peacekeepers Shouldn’t Always Be Peaceful
04/19/2018. The United Nations needs to accept that it’s possible to fight and broker peace agreements at the same time.
Africa for pessimists: 2017 in review
12/26/2017. By 2050, Africa’s population will more than double, from 1.2-billion today to 2.5-billion.